Proactive Investors - Run By Investors For Investors

Instem confirms revenue and profits from US NIEHS contract will be recognised in current year

The accounting treatment decided upon for the contract jibes with the line taken by investment analysts in their current year forecasts
As you were, investment analysts ...

Investment analysts who follow Instem Plc (LON:INS) will not have to revise their current year forecasts after the company tied up an accounting loose end.

Back in late March when it announced its 2016 results, the software group reported that a delayed order expanding the use of Provantis, Instem's primary pre-clinical software suite, at the US National Institute of Environmental Health Sciences (NIEHS), had recently been received and the bean counters were assessing the appropriate accounting treatment for revenue and profit recognition purposes.

Instem confirmed the contract revenues and profits from the order would be recognised in the current year, in line with the accounting treatments underpinning current market forecasts among the broking community.

Shares in Instem edged up 1.1% to 179.02p in a falling market.

CLICK HERE: For a daily round-up of all the Proactive news

View full INS profile View Profile

Instem Plc Timeline

Related Articles

Big Data
January 15 2018
The company is developing a Human Resources analytics product suite using the core technologies from its other applications
Network security
March 13 2018
The company was arguably late to change to a software-as-a-service model, but the change is beginning to take hold
Mergers & acquisitions - takeover
January 11 2018
"Vermeg's acquisition of Lombard Risk will create a leading global financial software provider," said Badreddine Ouali, founder and chairman of Vermeg

No investment advice

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

© Proactive Investors 2018

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use